VSEE (VSee Health) YoY EBITDA Growth: 30.65% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is VSee Health YoY EBITDA Growth?

VSee Health VSEE +11.79% YoY EBITDA Growth is 30.65% as of Jun. 2026. The stock has 5 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. VSee Health's YoY EBITDA Growth for the quarter that ended in Jun. 2026 was 30.65%.

VSee Health's EBITDA per Share for the three months ended in Jun. 2026 was $-0.04.

VSee Health YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for VSee Health's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

VSee Health YoY EBITDA Growth Chart

VSee Health Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
0.00 -512.05 -6.73 -1,449.32 91.94

VSee Health Quarterly Data
Dec21 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 83.55 101.96 -9.58 75.64 30.65

VSee Health YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

VSee Health's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(-0.456--5.655)/ | -5.655 |
=91.94 %

VSee Health's YoY EBITDA Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EBITDA Growth (Q: Jun. 2026 )
=(EBITDA per Share (Q: Jun. 2026 )-EBITDA per Share (Q: Jun. 2025 )) / | EBITDA per Share (Q: Jun. 2025 )) |
=(-0.043--0.062)/ | -0.062 |
=30.65 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 30.65% mean?
VSee Health (VSEE) has a YoY EBITDA Growth of 30.65% as of Jun. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for VSee Health and its competitors.
Is VSee Health's YoY EBITDA Growth too high?
VSee Health's current YoY EBITDA Growth is 30.65%.
How does VSee Health's YoY EBITDA Growth compare to HCTI and MNDR?
VSee Health's YoY EBITDA Growth of 30.65% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Healthcare Providers & Services company?
A good YoY EBITDA Growth depends on the Healthcare Providers & Services industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for VSee Health and its competitors. VSee Health's current YoY EBITDA Growth is 30.65%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is VSee Health stock overvalued right now?
VSee Health (VSEE) has a current YoY EBITDA Growth of 30.65%. The current YoY EBITDA Growth is 30.65%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For VSee Health (VSEE), the current YoY EBITDA Growth is 30.65% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

VSee Health Business Description

Address 980 N Federal Highway, Suite 304, Boca Raton, FL, USA, 33432
VSee Health Inc is a telehealth software platform offer a comprehensive telehealth platform for U.S. hospitals and enterprises. Through VSee Lab, the company offer a set of telehealth software building blocks, data connectors, and workflow templates that can be rapidly configured into the clients workflows. Companies offerings allow clinicians without programming experience to configure building blocks into their existing workflow without requiring programmers. These set of building blocks can connect to electronic medical record systems such as EPIC and Cerner via HL7, FHIR, and sFTP. The entire telehealth platform sits on a scalable server architecture and is HIPAA compliant and SOC2 externally audited.